Outcome of Fetal Spina Bifida
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Neural tube defects are one of the most prevalent congenital abnormalities, surpassed only by cardiac malformations. Spina bifida accounts for the majority of the neural tube defects and is comprised of a wide spectrum of anomalies ranging from small isolated sacral dysraphisms to large spinal defects. The origin of spina bifida is a failure of neurulation. It usually occurs at 15 days post-conception, resulting in a bony spinal defect with extrusion of the neural placode and/or the meninges outside of the spinal canal. Spina bifida has a prevalence of 1-5 in 1,000 live births and is the most complex congenital abnormality compatible to long-time survival. Concerning psychomotor development as well as urinary bladder and intestinal morbidity the prognosis ranges from normal functional outcome to severe disability.
The diagnosis of serious fetal abnormalities such as spinal dysraphism by ultrasound screening allows patients to prepare for the birth of an impaired child or to consider termination of the pregnancy. In current practice, prenatal counseling and obstetric management depend not only on the detection of a spinal dysraphism but also on an appropriate assessment of the severity of the defect and its possible impact on the postnatal development of the affected child.
Level and type of lesion, presence of associated anomalies (e.g., Chiari II malformation and ventriculomegaly) and mode of surgical closure are factors known to have prognostic impact on the postnatal outcome. Previous studies reported that postnatally determined lesion levels correlated well with functional status and survival. On the contrary, it is still not clear whether similar data obtained antenatally are of value.
In this study, the investigators will review their database of all cases of prenatally diagnosed spina bifida within a 16 year period between 1993 and 2009. By analyzing the prenatal and postnatal characteristics of fetuses with spina bifida in relation to the anatomic level of the lesion, the investigators aim to contribute further information regarding the natural course of affected pregnancies and the correlation of prenatal ultrasound findings with their functional outcome.
| Condition |
|---|
|
Pregnancy Fetal and Neonatal Health |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Retrospective |
| Official Title: | Fetal Spina Bifida -Prenatal Course and Outcome in 103 Cases A Single Center Experience. |
- pregnancy outcome [ Time Frame: 17 yrs ] [ Designated as safety issue: No ]To investigate the prenatal course and functional outcome of fetuses with spina bifida according to prenatal ultrasound exam.
- Infant psychomotor development [ Time Frame: 17 yrs ] [ Designated as safety issue: No ]
Kaufmann ABC
Denver Developmental Screening Test
walking ability
muscle strenght
- Infant bladder and bowel function [ Time Frame: 17 yrs ] [ Designated as safety issue: No ]Degree of continence.
- Conception date [ Time Frame: 17 yrs ] [ Designated as safety issue: No ]
- spectrum of ultrasound signs [ Time Frame: 17yrs ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 110 |
| Study Start Date: | December 2009 |
| Groups/Cohorts |
|---|
|
thoracal lesion
spinal lesion at thoracal level detected at prenatal ultrasound exam
|
|
lumbar lesion
spinal lesion at lumbar level detected at prenatal ultrasound exam
|
|
sacral lesion
spinal lesion at sacral level detected at prenatal ultrasound exam
|
Eligibility| Ages Eligible for Study: | 12 Weeks to 12 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Fetuses with spina bifida identified at prenatal ultrasound examination between 1993 and 2009
Inclusion Criteria:
- spina bifida identified at prenatal ultrasound examination
- ultrasound diagnosis between 1993 - 2009
Exclusion Criteria:
- deviant postnatal diagnosis
- loss to follow-up
- incomplete data
Contacts and Locations| Contact: Feriel Amari, M.D. | +49 451 500 2141 | feriel.amari@uk-sh.de |
| Contact: Klaus Diedrich, PhD | +49 451 500 2141 | klaus.diedrich@uk-sh.de |
| Germany | |
| Schleswig- Holstein University, Campus Lübeck, Department of Prenatal Medicine | Recruiting |
| Lübeck, Schleswig- Holstein, Germany, D- 23538 | |
| Contact: Feriel Amari, M.D. + 49 451 989 2663 feriel.amari@uk-sh.de | |
| Sub-Investigator: Daniel Beyer, M.D. | |
| Sub-Investigator: Wiebe Junkers, M.D. | |
| Sub-Investigator: David Hartge, M.D. | |
| Sub-Investigator: Martin Krapp, PhD | |
| Sub-Investigator: Ute Germer, PhD | |
| Sub-Investigator: Ulrich Gembruch, PhD | |
| Sub-Investigator: Roland Axt-Fliedner, PhD | |
| Principal Investigator: Jan Weichert, M.D. | |
| Principal Investigator: Feriel Amari, M.D. | |
| Principal Investigator: | Feriel Amari, M.D. | Schleswig- Holstein University, Lübeck |
| Study Director: | Jan Weichert, M.D. | Schleswig- Holstein University, Lübeck |
| Study Chair: | Klaus Diedrich, PhD | Schleswig- Holstein University, Lübeck |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Daniel Alexander Beyer, Dr. D. A. Beyer, University of Luebeck |
| ClinicalTrials.gov Identifier: | NCT01100697 History of Changes |
| Other Study ID Numbers: | UKSH-HL-09-181 |
| Study First Received: | April 2, 2010 |
| Last Updated: | August 22, 2011 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by University of Luebeck:
|
prenatal diagnosis ultrasound outcome spina bifida neural tube defect |
Additional relevant MeSH terms:
|
Spinal Dysraphism Neural Tube Defects Nervous System Malformations Nervous System Diseases Congenital Abnormalities |
ClinicalTrials.gov processed this record on May 16, 2013